Correspondence

Letter to medicines and medical products suppliers: 17 November 2020

DHSC's Chief Commercial Officer wrote to medicines and medical product suppliers, supply chain and businesses.

Documents

Details

The UK government and the European Commission have concluded their negotiations on the terms of trade between the 2 markets after the end of the transition period.

This does not remove any of the requirements to act now to prepare for new customs and border processes. The Department’s requests of industry set out in this letter remain valid and current.

This letter is written by Steve Oldfield, Chief Commercial Officer, on behalf of the Department of Health and Social Care (DHSC).

It reminds industry and the wider supply chain of the government’s plans for the end of the transition period to help ensure the continuity of supply of medical goods into and out of the UK.

Updates to this page

Published 17 November 2020
Last updated 28 December 2020 + show all updates
  1. Added message that DHSC's requests of industry set out in this letter remain valid and current, after the trade and cooperation agreement reached between the EU and the UK.

  2. First published.

Sign up for emails or print this page